We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




A Subcutaneous Patch Controls Medication Delivery

By HospiMedica staff writers
Posted on 12 Nov 2007
An inexpensive patch-sized miniature infusion pump promises to be able to inject both basal rates and user-initiated boluses of medications.

The PatchPump subcutaneous medication delivery button provides the convenience and simplicity of a transdermal patch, combined with the features of an infusion pump. More...
This provides a vehicle for pharma companies to re-package existing drugs within an enhanced delivery system, extending patent protection while providing an enhanced product to their customers. The PatchPump enables the delivery of basal and bolus combinations in a choice of drug volumes ranging between 0.5 and 5 cc. Typical operation time for the patch runs between 48 hours and one week. Dispersion methods include subcutaneous, intravenous (IV) and microneedle delivery, and a soft cannula insertion mechanism is integrated into the device. The electronic controller allows varying levels of sophistication, from simple and disposable to reusable, according to the desired pharmacological profile.

The PatchPump incorporates ECell technology, which merges the two major components of disposable pumps --the power source and the motor--into one simple miniature part, enabling the fabrication of very flat and simple devices. The ECell works like a solid-state battery cell that gradually expands in a stable manner under electronic control. This cell exerts pressure against an internal drug reservoir in the device, providing controlled drug release. The PatchPump is a product of SteadyMed (Tel Aviv, Israel).


Related Links:
SteadyMed

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.